Search by Drug Name or NDC

    NDC 00023-3348-07 OZURDEX 0.7 mg/1 Details

    OZURDEX 0.7 mg/1

    OZURDEX is a INTRAVITREAL IMPLANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is DEXAMETHASONE.

    Product Information

    NDC 00023-3348
    Product ID 0023-3348_9aafcf18-c506-4bd7-9521-de261a37626e
    Associated GPIs 86300010002320
    GCN Sequence Number 065561
    GCN Sequence Number Description dexamethasone IMPLANT 0.7 MG INTRAOCULR
    HIC3 Q6P
    HIC3 Description EYE ANTI-INFLAMMATORY AGENTS
    GCN 27558
    HICL Sequence Number 002889
    HICL Sequence Number Description DEXAMETHASONE
    Brand/Generic Brand
    Proprietary Name OZURDEX
    Proprietary Name Suffix n/a
    Non-Proprietary Name dexamethasone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form IMPLANT
    Route INTRAVITREAL
    Active Ingredient Strength 0.7
    Active Ingredient Units mg/1
    Substance Name DEXAMETHASONE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022315
    Listing Certified Through 2024-12-31

    Package

    NDC 00023-3348-07 (00023334807)

    NDC Package Code 0023-3348-07
    Billing NDC 00023334807
    Package 1 POUCH in 1 CARTON (0023-3348-07) / 1 IMPLANT in 1 POUCH
    Marketing Start Date 2009-09-01
    NDC Exclude Flag N
    Pricing Information N/A